Germanium-Fortified Yeast Activates Macrophage, NK Cells and B Cells and Inhibits Tumor Progression in Mice. |
Baek, Dae-Heoun
(Geranti Pharm. Ltd.)
Jung, Jin-Wook (Geranti Pharm. Ltd.) Sohn, Tsang-Uk (Geranti Pharm. Ltd.) Kang, Jong-Koo (College of Veterinary Medicine, Chungbuk National University, Biotoxtech Co., Ltd.) |
1 | Aso, H., F. Suzuki, T. Yamaguchi, Y. Hayashi, T. Ebina, and N. Ishida. 1985. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol. Immunol. 29: 65-74 DOI PUBMED |
2 | Bigitta, E. L., H. Mann, H. Melzer, L. Dunemann, and J. Begerow. 1999. Renal and other organ failure caused by germanium intoxication. Nephrol Dial Transplant 14: 2464-2468 DOI ScienceOn |
3 | Lee, J. H, K. W. Kim, M. Y. Yoon, J. Y. Lee, C. J. Kim, and S. S. Sim. 2005. Anti-inflammatory effect of germanium-concentrated yeast against paw oedema is related to the inhibition of arachidonic acid release and prostaglandin E2 production in RBL 2H3 cells. Autonomic & Autacoid Pharmacology 25: 129-134 DOI ScienceOn |
4 | Lee, J. S., J. I. Park, S. H. Kim, H. Y. Kee, Z. Z. Hwang, C. B. Park, T. U. Sohn, S. H. Shin, J. K. Kang, and Y. B. Kim. 2004. Oral single-and repeated-dose oxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeasts, in dogs. J. Toxicol. Sci. 29: 555-569 DOI ScienceOn |
5 | Schauss, A. G. 1991. Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide. Biological Trace Element Research 29: 267-280 DOI |
6 | Sohn, T. U., W. J. Song, S. C. Lee, and T. K. Oh. Process for preparing S. cerevisiae containing organically bound germanium. US Pat No. 5,792,646 |
7 | Suzuki, F. 1985. Suppression of tumor growth by isolated peritoneal macrophages from mice treated with carboxy-ethylgermanium sesquioxide (Ge-132). Japan J. Cancer Chemother. 12: 2122-2128 |
8 | Suzuki, E, R. R. Brutkiewicz, and R. B. Pollard. 1986. Cooperation of lymphokines and macrophages in expression of antitumor activity of carboxyehtylgermanium sesquioxide (Ge-132). Anticancer Research 6: 177-182 PUBMED |
9 | Swenson, F. J. and T. R. Kozel. 1978. Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages. Infection and immunity 21: 714-720 PUBMED |
10 | Badawi, A. M. and A. A. Hafiz. 2007. Synthesis and immunomodulatory activity of some novel amino acid germinates. J. Iran. Chem. Soc. 4: 107-113 DOI |
11 | Lee, S. H., K. N. Oh, S. N. Rho, B. H. Lee, and H. J. Lee. 2006. Oral repeated-dose toxicity studies especially in the liver and kidney of rats administered with organic germanium-fortified yeasts. J. Food. Sci. Nutr. 11: 115-119 과학기술학회마을 DOI |
12 | Okada, K., K. Okagawa, K. Kawakami, Y. Kuroda, K. Morizumi, H. Sato, H. Morita, S. Shimomura, and S. Saito. 1989. Renal railure caused by long-term use of a germanium preparation as an elixir. Clinical Nephrology 31: 219-224 PUBMED |
13 | Nobohiro, W., I. Osamu, K. Takuro, and Y. Koichi. 1980. New approaches to using spent brewer's yeast. ASBC J. 38: 5-8 |
14 | Fuggetta, M. P., C. D'Onofrio, and E. Bonmassar. 1990. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia. Ann Ist Super Sanita. 26: 385-395 |
15 | Faubert, G. M. 1976. Depression of the plaque-forming cells to sheep red blood cells by the new-born larvae of Trichinella spiralis. Immunology 30: 485-489 PUBMED |
16 | Fukazawa, H., Y. Ohashi, S. Sekiyama, H. Hoshi, M. Abe, M. Takahashi, and T. Sato. 1994. Multidisciplinary treatment of head and neck cancer using BCG, OK-432, and GE-132 as biologic response modifiers. Head Neck. 16: 30-38 DOI ScienceOn |
17 | Tao, S. H. and P. M. Bolger. 1997. Hazard assessment of germanium supplements. Regulatory Toxicology and Pharmacology 25: 211-219 DOI ScienceOn |
18 | Wright, S. D. and S. C. Silverstein. 1982. Tumor promoting phorbol ester stimulated C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes, J. Exp. Med. 156: 1149-1162 DOI ScienceOn |
19 | Lee, S. H., S. N. Rho, and T. U. Sohn. 2005. Efficacy study of activation on macrophage in germanium-fortified yeast. J. Korean Soc. Appl. Biol. Chem. 48: 246-251 과학기술학회마을 |
20 | Suzuki, F., R. R. Brutkiewicz, and R. B. Pollard. 1985. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132) Anticancer Res. 5: 479-483 PUBMED |
21 | Gadd, G. M. 1993. Microbial formation and transformation of organometallic and organometalloid compounds. FEMS Microbiology Reviews. 11: 297-316 DOI |
22 | Arimori, S., K. Watanabe, M. Yoshida, and T. Nagato. 1981. Effect of Ge-132 products and related synthetic compounds (Yamamura Y, S. Kotai, I. Azuma, A. Koda and T. Shiba. eds). Amsterdam ISBN Elsevier Science pp. 536-539 |
23 | Goodman, S. 1988. Medical Hyphothesis; Therapeutic effects of organic germanium. 26: 207-215 |
24 | Munakata, T., S. Arai, K. Kuwano, M. Furukawa and Y. Tomita. 1987. Induction of interferon production by NK cells by organogermanium compound, Ge-132. J. Interferon Research 7: 69-76 DOI ScienceOn |
25 | Pennline, K. A. and H. B. Herscowitz. 1981. Dual role for alveolar macrophages in humoral and cell-mediated immune response: evidence for suppressor and enhancing functions. J. Reticuloendothel. Soc. 30: 205-217 PUBMED |
26 | Rachanee, U., H. K. Webster, K. Pattanapanxyasa, S. Pitchayangkul, and S. Thaithong. 1992. Cytoadherence characteristics of rosette-forming Plasmodium falciparum. Infection and Immunity 60: 4483-4490 PUBMED |
27 | Lee, S. H., S. W. Oh, S. N. Rho, B. H. Lee, H. J. Lee and D. K. Jin. 2006. Effects of germanium-fortified yeast on the serum lipids and immune cell subset. J. Korean Soc. Food Sci. Nutr. 35: 1-7 DOI |
28 | Joo, S. S., T. J. Won, Y. J. Lee, M. J. Kim, S. Y. Park, S. H. Lee, K. W. Hwang, and D. I. Lee. 2006. Effect of Geranti Bio-Ge yeast, a dried yeast containing biogermanium, on the production of antibodies by B cells. Immune Network 6: 86-92 과학기술학회마을 DOI |
29 | Lee, J. S., J. I. Park, S. H. Kim, S. H. Park, S. K. Kang, C. B. Park, T. U. Sohn, J. Y. Jang, J. K. Kang, and Y. B. Kim. 2004. Oral single-and repeated-dose oxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeasts, in rats. J. Toxicol. Sci. 29: 541-553 DOI ScienceOn |
30 | Vachier, I., M. Damon, C. LeDoucen, A. C. dePaulet, P. Chanez, F. B. Michel and P. Godard. 1992. Increased oxygen species generation in blood monocytes of asthmatic patients. Am. Rev. Respir. Dis. 146: 1161-1166 DOI PUBMED ScienceOn |